Entyvio: Hyper-Focus on the Patient Journey

Takeda Pharmaceuticals, a pharmaceutical company, increased registrations for its Entyvio Connect program in the US by creating new datasets to inform a programmatic display and video outreach.


A Journey Challenge: Entyvio is a biologic indicated for Crohn's Disease and Ulcerative Colitis and is typically prescribed for moderatetosevere sufferers who have failed on more conservative therapies. Therefore, these sufferers are bio-naïve in that they have no experi

WARC subscribers can sign in to keep reading

Not a subscriber?

WARC helps you to plan, create and deliver more effective marketing

  • Prove your case and back-up your idea

  • Get expert guidance on strategic challenges

  • Tackle current and emerging marketing themes

WARC consistently delivers valuable insights that help to make me look like an expert in front of my colleagues and clients.

Dasha Boryso
Strategy Partner, Fetch

You’re in good company

We work with 80% of Forbes' most valuable brands* and 80% of the world's top top-of-the-class agencies.

* Top 10 brands